Scheduling, administration, biomarkers, and practical guidance.
4-8 weeks on, followed by equal duration off-cycle. Must inject immediately after reconstitution due to extreme instability.
4-8 weeks on, equal duration off. Higher dose used in performance and metabolic optimization contexts. Same instability precautions apply.
Short acute protocol for mitochondrial membrane stabilization. Monitor for injection site reactions and blood pressure changes.
Based on Phase 1b fatty liver trial dosing. Requires medical supervision and regular biomarker monitoring throughout.
Khavinson protocol for telomerase activation and pineal gland support. Commonly cycled biannually.
Neuroprotective MDP encoded by 16S rRNA gene. Primarily studied for amyloid-beta toxicity protection. Dosing extrapolated from preclinical models.
MOTS-c activates AMPK and glucose clearance pathways, which align with morning cortisol rhythm. Morning dosing also avoids insomnia risk reported as a side effect.
Maintain steady-state cardiolipin binding. Monitor blood pressure post-injection during waking hours for safety.
Epitalon supports pineal gland function and melatonin regulation. Evening administration aligns with the natural melatonin secretion window.
MOTS-c mimics exercise signaling via AMPK. Stacking with actual exercise may blunt adaptive training response. Separate the signals.